Literature DB >> 7123576

Changes in plasma lipoprotein levels during medication with a glucoside-hydrolase inhibitor (acarbose).

Y Homma, N Irie, Y Yano, N Nakaya, Y Goto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7123576

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN： 0385-0005


× No keyword cloud information.
  3 in total

1.  Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias.

Authors:  M Malaguarnera; I Giugno; P Ruello; M Rizzo; M Motta; G Mazzoleni
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 2.  Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  S P Clissold; C Edwards
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 3.  A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.

Authors:  F Santeusanio; P Compagnucci
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.